Literature DB >> 9695189

Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.

K A Siminovitch1, B G Neel.   

Abstract

Tyrosyl phosphorylation plays a key role in B lymphocyte signaling. The mechanisms by which protein tyrosine kinases (PTKs) regulate signaling pathways in B cells have been investigated extensively. More recently, attention has turned to the protein--tryosine phosphatases (PTPs), particularly those containing SH2 domains. SHP-1 has been shown to be a critical regulator of antigen receptor signaling, acting, at least in part, via inhibitory co-receptors containing SHP-1 binding sites. These studies have been aided considerably by the analysis of mice carrying naturally-arising mutations in the SHP-1 gene as well as mice bearing targeted mutations in other components of Be cells signaling pathways. The function of SHP-2 in B cells in less clear, although studies in other cell systems suggests that it may play a signal-enhancing role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695189     DOI: 10.1006/smim.1998.0125

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  10 in total

1.  Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Authors:  Christopher C Stebbins; Carsten Watzl; Daniel D Billadeau; Paul J Leibson; Deborah N Burshtyn; Eric O Long
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

2.  Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Authors:  L M Shaw
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.

Authors:  T Oka; T Yoshino; K Hayashi; N Ohara; T Nakanishi; Y Yamaai; A Hiraki; C A Sogawa; E Kondo; N Teramoto; K Takahashi; J Tsuchiyama; T Akagi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 4.  Protein tyrosine phosphatase function: the substrate perspective.

Authors:  Tony Tiganis; Anton M Bennett
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

Review 5.  Signaling defects in anti-tumor T cells.

Authors:  Alan B Frey; Ngozi Monu
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

6.  src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.

Authors:  Tohru Kamata; Masakatsu Yamashita; Motoko Kimura; Kaoru Murata; Masamichi Inami; Chiori Shimizu; Kaoru Sugaya; Chrong-Reen Wang; Masaru Taniguchi; Toshinori Nakayama
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 7.  Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors.

Authors:  Diwakar Davar; Hassane M Zarour
Journal:  Methods Mol Biol       Date:  2020

Review 8.  Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Authors:  Carol T Cady; Jeffrey S Rice; Vanessa L Ott; John C Cambier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

9.  Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses.

Authors:  C H Kim; C K Qu; G Hangoc; S Cooper; N Anzai; G S Feng; H E Broxmeyer
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

10.  Themis-associated phosphatase activity controls signaling in T cell development.

Authors:  Monika Mehta; Joanna Brzostek; Elijah W Chen; Desmond W H Tung; Shuting Chen; Shvetha Sankaran; Jiawei Yap; Vasily Rybakin; Nicholas R J Gascoigne
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-09       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.